Search - tctmd.com

Displaying 1 - 20 of 165

Sort: Relevancy | Date

Presentation TCT 2025

EFS in the US is Back! What’s needed for EFS 2.0 to Maintain and Grow the Program?

Presenter: Michael J. Mack

October 28, 2025

Presentation TCT 2025

Surgeon's Viewpoint

Presenter: Michael J. Mack

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

Presentation TCT 2020

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

Presenter: Michael Mack

October 16, 2020

Presentation TCT 2020

Heart Valve Collaboratory Is Next in Line

Presenter: Michael Mack

October 14, 2020

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Michael Mack

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

Presentation TCT 2019

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Presenter: Michael Mack

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

Advertisement

EFS in the US is Back! What’s needed for EFS 2.0 to Maintain and Grow the Program?

Surgeon's Viewpoint

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

What’s Going to Be Hot at TCT 2025

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

TAVR in Aortic Bioprosthetic Valve Failure - Thoughtful Perspectives From a Surgeon on Valve-in-Valve TAVR

Heart Valve Collaboratory Is Next in Line

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Surgical Volume Matters When It Comes to Repair of Primary MR

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Portico Noninferior to Commercial TAVR Valves in IDE Study

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content